© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Outlook Therapeutics, Inc. (OTLK) shows an Average True Range (ATR) of 0.23 and an Enterprise Value of 203.18M. Its average trading volume over the past 3 months is 3.18M, indicating liquidity. These fundamental metrics provide insight into OTLK's underlying financial health and market activity.
Outlook Therapeutics, Inc. (OTLK) technical indicators as of December 23, 2025: the SMA 20 is -7.12%, SMA 50 at 11.92%, and SMA 200 at 13.61%. The RSI 14 value is 47.79, suggesting its current momentum. These technical analysis signals help assess OTLK's price trends and potential future movements.
Outlook Therapeutics, Inc. (OTLK) stock performance overview as of December 23, 2025: The 52-week high is $3.39 (currently -45.72% below), and the 52-week low is $0.79 (currently 132.91% above). Over the past year, OTLK's performance is 28.67%, compared to the S&P 500's 10.56% change.
According to market data, Outlook Therapeutics, Inc. (OTLK) stock's recent performance metrics show that over the last month, OTLK is -6.12%, with a Year-to-Date (YTD) performance of -2.65%. Over the past year, the stock has seen a 28.67% change. These figures summarize OTLK's price movements across various periods, reflecting its historical returns.
According to current financial data, OTLK stock's P/E (TTM) ratio is -1.60, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for OTLK, including P/S (49.98), P/B (0.00), and P/FCF (-1.48), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.